Alain Hendlisz
Impact in
- Oncology top 0.2%
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 162
- Colorectal Cancer Treatments and Studies 99
- Pancreatic and Hepatic Oncology Research 29
- Cancer Immunotherapy and Biomarkers 25
- Hepatology 37
- Hepatocellular Carcinoma Treatment and Prognosis 36
- Co-authors
- Eric Van CutsemBart NeynsMarc PeetersSalvatore SienaJean–Luc Van LaethemRafael G. AmadoMichael WolfYves Humblet
- Journals
- Journal of Clinical Oncology (39 papers)Annals of Oncology (20 papers)Current Opinion in Oncology (9 papers)Cancer Treatment Reviews (7 papers)Cancer Research (6 papers)
- Partner nations
- BelgiumUnited StatesItaly
In The Last Decade
Alain Hendlisz
200 papers receiving 7.0k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Oncology 5.2k
- Hepatology 1.2k
- Pathology and Forensic Medicine 1.4k
- Cancer Research 948
- Pulmonary and Respiratory Medicine 2.0k
Countries citing papers authored by Alain Hendlisz
This map shows the geographic impact of Alain Hendlisz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alain Hendlisz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alain Hendlisz more than expected).
Fields of papers citing papers by Alain Hendlisz
This network shows the impact of papers produced by Alain Hendlisz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alain Hendlisz. The network helps show where Alain Hendlisz may publish in the future.
Co-authors
The 25 scholars most cited alongside Alain Hendlisz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 5 | |
| 4 | 2023 | 4 | |
| 5 | 2021 | 13 | |
| 6 | 2020 | 4 | |
| 7 | 2020 | 25 | |
| 8 | 2019 | 2 | |
| 9 | 2019 | 48 | |
| 10 | Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer Hit paper breakdown → | 2018 | 1429 |
| 11 | 2018 | 40 | |
| 12 | 2017 | 42 | |
| 13 | 2016 | 1 | |
| 14 | 2014 | 1 | |
| 15 | 2012 | 94 | |
| 16 | Prospective Randomised Trial Comparing Protracted Iv 5fu Infusion Alone Or With Hepatic Intra-arterial Injection of Yttrium-90 Resin Microspheres for Patients With Liver-limited Metastatic Colorectal Cancer Refractory To Standard Chemotherapy | 2010 | 1 |
| 17 | Treatment effect of panitumumab in subsets by epidermal growth factor receptor (EGFR) status from a phase 3 randomized controlled trial | 2006 | 2 |
| 18 | Peginterferon alpha-2a (40kDa) plus ribavirin is as effective in patients relapsing after conventional interferon based therapy as in naive patients: Results from the Bernar-1 trial | 2005 | 3 |
| 19 | A phase I study of BAY 43-9006, a novel Raf kinase and VEGFR inhibitor, in combination with taxotere in patients with advanced, solid tumors | 2004 | 4 |
| 20 | Phase I clinical and pharmacology study of the novel epothilone analog BMS-247550 given weekly in patients advanced solid tumors | 2001 | 6 |
About Alain Hendlisz
Alain Hendlisz is a scholar working on Oncology, Hepatology, Pathology and Forensic Medicine, Cancer Research and Pulmonary and Respiratory Medicine, having authored 209 papers that have together received 7.1k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (99 papers), Hepatocellular Carcinoma Treatment and Prognosis (36 papers), Genetic factors in colorectal cancer (30 papers), Pancreatic and Hepatic Oncology Research (29 papers), Cancer Immunotherapy and Biomarkers (25 papers), Radiomics and Machine Learning in Medical Imaging (25 papers), Gastric Cancer Management and Outcomes (23 papers) and Cancer Genomics and Diagnostics (22 papers). The work is most often cited by research in Oncology (5.2k citations), Hepatology (1.2k citations), Pathology and Forensic Medicine (1.4k citations), Cancer Research (948 citations) and Pulmonary and Respiratory Medicine (2.0k citations). Alain Hendlisz has collaborated with scholars based in Belgium, United States and Italy. Frequent co-authors include Eric Van Cutsem, Bart Neyns, Marc Peeters, Salvatore Siena, Jean–Luc Van Laethem, Rafael G. Amado, Michael Wolf, Yves Humblet, Heinz‐Josef Lenz and Gary Richardson. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Current Opinion in Oncology, Cancer Treatment Reviews and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.